The HIV virus also changes often, developing new strains, which complicates finding a consistent immune response. In contrast to Imbokodo, the booster in Mosaico includes external coat proteins from a larger variety of HIV strains.Other researchers are exploring a variety of new approaches, including the mRNA technology which was successfully used in the Pfizer and Moderna COVID-19 vaccines.